Altogether, these findings indicated that myeloid cells favor tumor immunoevasion in a process dependent on EGFR and MAPK-mediated regulation of tumoral PD-L1 expression and inhibition of CD8+ T cell antitumor immunity. The gene discussed is CD8A; the disease is neoplasm.